hotspot -WSS

hotspot

author：Wikipedia 2025-10-06 09:44:26 - browse：6278

Primary care exam 01 — ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and Medtronic have run studies that showed renal denervation leads to a modest decrease in blood pressure. Adam Berry/Getty Images

The Food and Drug Administration approved a surgical system used to reduce blood pressure from Recor Medical, the company announced Wednesday. The treatment, called renal denervation, is controversial in the cardiology community due to its unclear efficacy.

Renal denervation is a treatment for patients who cannot manage standard doses of blood pressure medication — whether because the drugs aren’t effective enough for them, create overwhelming side effects, or become too cumbersome. The therapy, which is meant to be a one-time procedure, is administered via a catheter. Electrodes on the catheter then emit radiofrequency or ultrasound energy to block nerve signals from the kidneys that increase blood pressure.

The therapy, a simple procedure to reduce the blood pressure of millions of Americans, was once seen as a boon for cardiologists and device makers. But a large-scale clinical trial from Medtronic in 2014 called renal denervation’s efficacy into question, as it did not significantly reduce blood pressure compared to placebo treatments.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Senators: Long

WSS

Ukraine and a new approach to mental health in war

What Congress can do to address the rural doctor shortage

Colonoscopy prep: Liquid

Intermittent fasting comes with a heart risk? Not so fast

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Creating egg and sperm cells from stem cells raises ethical issues

explore

hotspot

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Medical leaders decry Supreme Court decision on affirmative action

Ukraine and a new approach to mental health in war

DIEP, the 'gold standard' of breast reconstruction, is under threat

Orchard's therapy for neuron disease in children wins FDA approval

Hollywood unions extend contract negotiations for actors

Intermittent fasting comes with a heart risk? Not so fast

The high cost of giving birth even with insurance

Senators: Long

hotspot

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Experts study whether long Covid risk adds up with each reinfection

CDC's new outbreak response network to include Northeastern

How Vertex's cystic fibrosis drug is changing patients' lives

Intermittent fasting comes with a heart risk? Not so fast

Positive childhood experiences can help future health

hotspot

hotspot

Wikipedia

knowledge